Using multiple measures of glycemia to support individualized diabetes management: recommendations for clinicians, patients, and payers.

By the year 2030, the diabetes pandemic will likely affect more than 10% of the world's population. The personal, public health, and economic crises implicit in this trend call for decisive action. Yet, escalating dilemmas thwart full realization of current therapies.